Altria Group, Inc. News
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; moist smokeless tobacco products and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; and on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia.
see moreAltria Group, Inc. Market News
11d
Altria (MO) Faces NJOY Setback, 10% Yield Draw Now
- Altria (MO) is navigating a new phase after a significant e‑vapor impairment tied to NJOY ACE, while its dividend yield has drawn income investors. Recent data show modest share weakness alongside strategic reaffirmation of 2026 guidance and continued pressure on combustible volumes.
25d
Altria (MO): RS Upgrade, on! PLUS FDA Boost Uptick
Altria’s RS rating improvement, FDA authorization for on! PLUS nicotine pouches, and reaffirmed 2026 guidance are shifting investor sentiment. Technical breakout into a cup-with-handle buy zone supports near-term upside, while illicit disposable e-vapor products remain a material headwind to smoke-free adoption.
24 Feb at 14:34
Altria MO: Q4 EPS Miss, NJOY Exit, Pouch Pivot -Q1
Altria reported a narrow Q4 EPS miss and continued cigarette volume declines while withdrawing NJOY Ace from the U.S., reinforcing a strategic pivot toward on! nicotine pouches and steady capital returns amid regulatory headwinds.
17 Feb at 14:17
Altria Q4 Miss, Illicit Vapes Weigh on MO Stock!!!
Altria's recent quarter missed expectations as illicit disposable vapes and legal setbacks on vaping devices forced a $1.3B impairment and pressured growth in smoke‑free categories. Strong cigarette margins continue to produce cash flow, but the on! nicotine‑pouch rollout, FDA enforcement funding, and litigation outcomes are the near‑term catalysts for MO stock.
10 Feb at 14:17
Altria (MO) Rally: Dividends, Buybacks, and Risks!
Altria’s (MO) stock shows technical momentum and steady shareholder returns but faces headwinds from weakening cigarette volumes, competitive pressure in nicotine pouches, a recent EPS miss, and regulatory/legal costs. Key drivers this week: Q4 results, a $1.3B impairment, rising RS rating, continued dividend yield (~6.8–7%), and a $2B buyback authorization. Investors should watch pouch market share, FDA actions, and confirmation of the technical breakout.